Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

in vitro antileukemic activity

  • You have access
    Comparison of In Vitro Antileukemic Activity of 4-Hydroperoxyifosfamide and 4-Hydroperoxycyclophosphamide
    MALGORZATA OPYDO-CHANEK, KATARZYNA ŚLADOWSKA, KAMIL BLICHARSKI, JAROMIR MIKEŠ, PETER FEDOROČKO, ULF NIEMEYER and LIDIA MAZUR
    Anticancer Research November 2017, 37 (11) 6355-6361;
  • You have access
    Effects of Structural Modifications of Daunorubicin on In Vitro Antileukemic Activity
    MARTA STOJAK, LIDIA MAZUR, MAŁGORZATA OPYDO-CHANEK, MAŁGORZATA ŁUKAWSKA and IRENA OSZCZAPOWICZ
    Anticancer Research December 2012, 32 (12) 5271-5277;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire